Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease

被引：1
|
作者：
De la Garza-Salazar, Fernando
Colunga-Pedraza, Perla Rocio
Coronado-Alejandro, Edgar Ulises
Gutierrez-Aguirre, Cesar Homero
Cantu-Rodriguez, Olga Graciela
Gomez-Almaguer, David [1 ,2 ]
机构：
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Hematol Serv, Internal Med Dept, Monterrey, Mexico
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 03期
关键词：
chronic graft versus host disease; CYP; ibrutinib; itraconazole; low dose;
D O I：
10.1111/bjh.18712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：573 / 576
页数：4
相关论文
共 50 条
  • [21] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Krejci, M
    Doubek, M
    Buehler, T
    Brychtova, Y
    Vorlicek, J
    Mayer, J
    ANNALS OF HEMATOLOGY, 2005, 84 (10) : 681 - 685
  • [22] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Aliana Meneses Ferreira
    Carolina Atallah Pontes da Silva
    André Domingues Pereira
    Roberta Shcolnik Szor
    Ana Rita Brito Medeiros da Fonseca
    Mariana Gomes Serpa
    Erick Menezes Xavier
    Michelly Kerly Sampaio de Melo
    Yana Novis
    Luciana Tucunduva
    Vanderson Rocha
    Celso Arrais-Rodrigues
    Bone Marrow Transplantation, 2018, 53 : 503 - 506
  • [23] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Kaloyannidis, Panayotis
    Al Shaibani, Eshrak
    Apostolidis, Ioannis
    Kanfar, Solaf
    Al Anezi, Khalid
    Al Hashmi, Hani
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 746 - 748
  • [24] Steroid-Refractory Chronic Graft-Versus-Host Disease: Treatment Options and Nursing Care
    Cazeau, Naomi
    Rodriguez, Stephany
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (03) : 259 - 265
  • [25] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Ferreira, Aliana Meneses
    Pontes da Silva, Carolina Atallah
    Pereira, Andre Domingues
    Szor, Roberta Shcolnik
    Brito Medeiros da Fonseca, Ana Rita
    Serpa, Mariana Gomes
    Xavier, Erick Menezes
    Sampaio de Melo, Michelly Kerly
    Novis, Yana
    Tucunduva, Luciana
    Rocha, Vanderson
    Arrais-Rodrigues, Celso
    BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 503 - 506
  • [26] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
    Daniel Wolff
    Giancarlo Fatobene
    Vanderson Rocha
    Nicolaus Kröger
    Mary E. Flowers
    Bone Marrow Transplantation, 2021, 56 : 2079 - 2087
  • [27] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Panayotis Kaloyannidis
    Eshrak Al Shaibani
    Ioannis Apostolidis
    Solaf Kanfar
    Khalid Al Anezi
    Hani Al Hashmi
    Bone Marrow Transplantation, 2019, 54 : 746 - 748
  • [28] TozinameranWorsening of chronic graft-versus-host disease and steroid-refractory immune thrombocytopenia: 2 case reports
    Reactions Weekly, 2022, 1905 (1) : 487 - 487
  • [29] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
    Wolff, Daniel
    Fatobene, Giancarlo
    Rocha, Vanderson
    Kroeger, Nicolaus
    Flowers, Mary E.
    BONE MARROW TRANSPLANTATION, 2021, 56 (09) : 2079 - 2087
  • [30] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Marta Krejci
    Michael Doubek
    Tomas Buchler
    Yvona Brychtova
    Jiri Vorlicek
    Jiri Mayer
    Annals of Hematology, 2005, 84 : 681 - 685
12345